Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
7.34
+0.34 (4.86%)
At close: Apr 22, 2026, 4:00 PM EDT
7.36
+0.02 (0.26%)
After-hours: Apr 22, 2026, 7:54 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $537.63 million as of April 22, 2026. Its market cap has increased by 136.14% in one year.
Market Cap
537.63M
Enterprise Value
466.94M
1-Year Change
136.14%
Ranking
Category
Stock Price
$7.34
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $537.63M, an increase of 141.75%. That is a compound annual growth rate of 20.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 512.73M | 65.30% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 562.45M |
| Verastem | 555.17M |
| ADC Therapeutics | 546.29M |
| enGene Therapeutics | 545.29M |
| Upstream Bio | 535.49M |
| Sutro Biopharma | 534.62M |
| Tectonic Therapeutic | 534.20M |
| Valneva SE | 531.45M |